KANJINTI

Google image searchProduct monograph

Active ingredient

trastuzumab, 420 MG/VIAL

DIN: 02496690

Dosage form(s): KIT, POWDER FOR SOLUTION

Route(s) of administration: INTRAVENOUS

Schedule: Prescription / Schedule D

Company: AMGEN CANADA INC

Date: 16-APR-2020

ATC:

Reference brand drug: Herceptin

Search on Google